BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy

Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli, Özlem Aydın İsak, Doğan Yazılıtaş, Gökşen İnanç İmamoğlu, Ömer Bayır · 2025

Read BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy by Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli, Özlem Aydın İsak, Doğan Yazılıtaş, Gökşen İnanç İmamoğlu, Ömer Bayır (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12706939.txt.

Description

Esra Zeynelgil and co-authors ask which patients with advanced head and neck cancer fail to finish chemoradiation. The patients first get three rounds of induction chemo. Their 2025 study reads records from 2014 to 2024 at one oncology clinic. In all, 92 patients who could not have surgery or organ-sparing care were tracked. Blood marks, body measures, and health scores were all weighed.

Five traits flagged those who stopped early. Age past sixty, other illnesses, low body mass, weak daily function, and a low nutrition index all raised the risk. A low body mass mark also tracked with shorter survival. The team builds a small model from four of the traits. Such gauges could flag who needs support before treatment starts.

Catalog record

CREATOREsra Zeynelgil, Engin Eren Kavak, İsmail Dilli, Özlem Aydın İsak, Doğan Yazılıtaş, Gökşen İnanç İmamoğlu, Ömer Bayır
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12706939

Browse the full library · About the Tower of Babel